The Cardinal Source
CCaaS migration sourcing brief.
Acme Manufacturing · 78 locations · FDA-regulated medical device
Executive summary
Acme Manufacturing is replacing a legacy Cisco on-premises contact center across 78 locations. The current platform is end-of-life in 2027 and fails to satisfy three operational requirements: 21 CFR Part 11 audit trails for clinical-affairs inbound calls, HIPAA-aware call recording with discoverable transcripts, and integration with the company's complaint management system (MasterControl).
This brief reframes the request from "we need a new CCaaS" to "we need an FDA-aware contact center that supports 21 CFR Part 11 audit trails, HIPAA inbound handling, and MasterControl integration — deployable across 78 manufacturing and clinical-affairs sites without disruption to existing complaint-handling SOPs."
Current state inventory
Incumbent platform
Cisco Unified Contact Center Enterprise (UCCE) 12.5, deployed 2017. On-premises infrastructure across two primary data centers (Indianapolis and Phoenix) with site survivability at 76 of 78 locations. End-of-software-maintenance scheduled for January 2027.
Contract structure
| Component | Vendor | Annual cost | Renewal |
|---|---|---|---|
| UCCE Enterprise Licenses (360 seats) | Cisco | $485,000 | 2027-01-15 |
| Carrier voice (SIP trunking, 240 sessions) | Lumen | $168,000 | 2026-09-30 |
| Call recording (Verint) | Verint | $94,000 | 2027-03-01 |
| Workforce management (Aspect) | Aspect Software | $72,000 | 2026-12-31 |
| Total annual | $819,000 |
Operational metrics (current)
- Average handle time (AHT): 8 min 22 sec
- First call resolution (FCR): 71%
- Inbound call volume: 14,200/month average
- Concurrent agents at peak: 312 of 360 licensed
- Integrations in use: MasterControl, ServiceNow, Salesforce Service Cloud
What we are actually solving for
Three constraints define this engagement and shape every downstream decision:
Constraint 1 — 21 CFR Part 11 audit compliance
FDA inspection readiness requires that any system handling clinical-affairs or complaint-related communications produce tamper-evident audit trails. Most CCaaS vendors generate call recordings; few generate cryptographically-signed audit logs that satisfy 21 CFR Part 11 §11.10(e). The shortlist must include vendors with proven Part 11 implementations at peer device manufacturers.
Constraint 2 — MasterControl integration depth
Acme's complaint-handling SOP requires that every inbound complaint call be created as a MasterControl complaint record within four minutes of call termination, with the full transcript attached. Off-the-shelf API integrations exist for most CCaaS vendors but the field maturity varies widely. Shortlist must include vendors with production MasterControl deployments at scale.
Constraint 3 — Deployment risk tolerance
The FDA Form 483 risk associated with disrupting complaint-handling continuity is high. Migration cannot involve site-by-site cutover that puts any individual site offline for more than four business hours, and rollback to UCCE must remain viable for the first 90 days post-cutover at every site.
Success criteria
| Dimension | Target | Method of verification |
|---|---|---|
| 21 CFR Part 11 compliance | Audit-ready by go-live | Third-party audit + FDA pre-inspection |
| Integration to MasterControl | ≤4-min call→record creation | SLA monitoring during 30-day burn-in |
| Annual run-rate | ≤$671,580 (18% below current) | Year-1 financial reconciliation |
| Implementation | All 78 sites by 2026-12-31 | Site-by-site cutover plan + tracker |
| Operational continuity | Zero unplanned outage >4 hr | Incident log review |
Budget envelope
Year-1 implementation budget: $1.1M one-time (includes professional services, training, parallel-run period). Year-2+ run-rate target: $671,580 annually or below.
Approved by VP, Information Technology and CFO on 2026-05-22. Subject to revised approval if final TCO exceeds Year-2 target by more than 8%.
Stakeholders
| Name | Role | Engagement |
|---|---|---|
| [Redacted] | VP, Information Technology | Decision authority |
| [Redacted] | Director, Quality Assurance | FDA / Part 11 validation |
| [Redacted] | Director, Customer Experience | Operational requirements |
| [Redacted] | Manager, IT Infrastructure | Technical implementation |
| [Redacted] | External counsel | Contract review |
Next steps
This Sourcing Brief is the Stage 1 deliverable in The Cardinal Method. Subsequent stages produce three additional deliverables:
- Category Map (Stage 2 · East Wind) — confirms CCaaS is the right category vs. alternatives (e.g., voice analytics overlay + UCaaS, or hybrid retention of UCCE for clinical-affairs only).
- Vendor Scorecard (Stage 3 · South Spine) — qualified CCaaS vendors scored against Acme's specific weights (21 CFR Part 11 weighted at 25%).
- Decision Memo (Stage 4 · West Frontier) — board-ready written recommendation with implementation plan.